4536:TYO
Santen Pharmaceutical Co Ltd
2 035,00 JP¥
arrow_upward
+1,67%(+33,50) 1D
13-ноя., 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4536...
Open
1 996 JP¥
High
2 036 JP¥
Low
1 973 JP¥
Mkt. cap
655,91 млд
Avg. vol.
1,32 млн
Volume
1,49 млн
Dividend
1,97%
Quarterly dividend
10 JP¥
Ex-dividend date
2027-ж., 30-мар.
P/E ratio
16,83
52-wk high
2 254 JP¥
52-wk low
1 533 JP¥
EPS
121 JP¥
Shares outstanding
407,09 млн
No. of employees
4 миң
Open
1 996 JP¥
High
2 036 JP¥
Low
1 973 JP¥
Mkt. cap
655,91 млд
Avg. vol.
1,32 млн
Volume
1,49 млн
Dividend
1,97%
Quarterly dividend
10 JP¥
Ex-dividend date
2027-ж., 30-мар.
P/E ratio
16,83
52-wk high
2 254 JP¥
52-wk low
1 533 JP¥
EPS
121 JP¥
Shares outstanding
407,09 млн
No. of employees
4 миң
News stories
From web sources and news partners
Benzinga
·
19 мүнөт мурун
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
TheStreet
·
1 саат мурун
Berkshire’s record high exposes hidden trap in S&P 500 401(k) plans
BigGo Finance
·
7 саат мурун
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 саат мурун
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3,97 миң
Founded1890
HeadquartersOsaka, Kansai, Япония
SectorHealth Care
IndustryPharmaceutical industry
Websitesanten.com